ICD less than 9 months from diagnosis of nonischemic cardiomyopathy
| ICD Guidelines Microchapters |
| Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities |
| Expert Consensus on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials |
|
ICD Implantation in the Context of an Abnormal Troponin that is Not Due to a Myocardial Infarction |
|
ICD Implantation Less Than 9 Months From The Initial Diagnosis of Nonischemic Cardiomyopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
ICD Implantation <9 MONTHS From The Initial Diagnosis Of Nonischemic Cardiomyopathy[1]
| Recommended |
| "1.In patients <9 months from the initial diagnosis of NICM who require nonelective permanent pacing, who would meet primary prevention criteria for implanta- tion of an ICD, and recovery of left ventricular function is uncertain or not expected, implantation of an ICD with the appropriately selected pacing abilities is recommended." |
| "2. In patients <9 months from the initial diagnosis of NICM with sustained (or hemodynamically significant) ventricular tachyarrhythmia, implantation of an ICD is recommended." |
| Can be Useful |
|
"1. If recovery of left ventricular function is unlikely, implantation of an ICD for primary prevention can be useful between 3 and 9 months after initial diagnosis of NICM." |
|
"2.In patients <9 months from the initial diagnosis of NICM with syncope that is thought to be due to a ven- tricular tachyarrhythmia (by clinical history or docu- mented NSVT), implantation of an ICD can be useful." |
|
"3. In patients <9 months from the initial diagnosis of NICM who have been listed for heart transplant or implanted with a left ventricular assist device, implantation of an ICD can be useful." |
| Not Recommended |
|
"1. Implantation of an ICD for primary prevention is not recommended within the first 3 months after initial diagnosis of NICM." |
- ↑ Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L (2014). "HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials". J. Am. Coll. Cardiol. 64 (11): 1143–77. doi:10.1016/j.jacc.2014.04.008. PMID 24820349.